Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor

The COVID-19 pandemic caused by the severe acute syndrome virus 2 (SARS-CoV-2) has been around since November 2019. As of early June 2022, more than 527 million cases were diagnosed, with more than 6.0 million deaths due to this disease. Coronaviruses accumulate mutations and generate greater divers...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade, Sonia Aparecida, Batalha-Carvalho, João Victor, Curi, Rui, Wen, Fan Hui, Covas, Dimas Tadeu, Chudzinski-Tavassi, Ana Marisa, Moro, Ana Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310548/
https://www.ncbi.nlm.nih.gov/pubmed/35898497
http://dx.doi.org/10.3389/fimmu.2022.871874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310548/
https://www.ncbi.nlm.nih.gov/pubmed/35898497
http://dx.doi.org/10.3389/fimmu.2022.871874

Ejemplares similares